repurposing semaglutide and liraglutide for alcohol use disorder Effects of glucagon-like peptide-1 receptor agonists on consumption: a systematic review meta-analysis Five Addiction Treatments That Might

Efficacy of Chinese herbal medicine in functional dyspepsia: a meta-analysis of randomized, double-blind, placebo-controlled trials

In Ozempic clinical trials , nausea was reported in 15.8 percent of people taking a 0.5-milligram (mg) dose and 20.3 percent of those on a 1-mg dose

In clinical studies, higher levels of circulating long- and medium-chain acylcarnitines showed mixed results in patients with Alzheimers disease [24, 25] whereas clinical trials of patients with Parkinsons disease have consistently shown that circulating levels of long-chain acylcarnitines are decreased [26,27,28]

preferred with established CVD or high CVD risk